FDA Approves PAXIL — Apotex Corp

Apotex Corp's launch of the generic version of Paxil (paroxetine hydrochloride) introduces increased competition into the depression and anxiety market, which historically has been dominated by Pfizer. This development is projected to significantly impact generic market share while potentially lowering costs for patients prescribed the oral medication.